BioSpace News Archive

Vicarious Surgical Inc. announced that renowned surgeon Igor Belyansky, MD, used the Vicarious Surgical Beta 2 prototype, to successfully perform two cadaveric ventral hernia repair procedures.

dentalcorp Holdings Ltd. (“dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest growing networks of dental practices, announced today that it intends to present at two upcoming investor conferences.

Alveo Technologies, Inc. announced the appointment of three life sciences industry leaders to its senior executive team to advance the development of its novel molecular sensing and diagnostics technology and lead the company through strategic growth and commercialization of its rapid, multiplexed molecular diagnostic platform, be.well™.

The global synthetic biology market size was USD 9.26 Billion in 2021 and is expected to register a revenue CAGR of 26.3% during the forecast period.

The global MicoRNA (miRNA) Market was valued at USD 190.6 Million in 2020 and is expected to reach USD 458.0 Million by 2030, at a CAGR of 11.6%.

The global antibody-drug conjugates (ADCs) market size was significantly large in 2020, and is expected to continue to register a rapidly inclining revenue CAGR between 2021 and 2030

The global cancer biomarkers market size was USD 27.83 Billion in 2021, and is expected to register a revenue CAGR of 17.6% during the forecast period.

Qualis Innovations Inc. currently trades under symbol “QLIS”, recently announced its financial 10-Q report on November 14, 2022.

ERS Genomics Limited is pleased to announce ATLATL Innovation Centre as its non-exclusive agent for licensing ERS’ intellectual property for commercial and/or research use in China.

InSitu Biologics, Inc. will share the latest investigational work on its multi-phase drug delivery matrix at the upcoming 21st Annual Pain Medicine Meeting of the American Society of Regional Anesthesia on November 18th , 2022.